Package 0904-7505-04

{"route": ["ORAL"], "spl_id": "a51e3361-63f9-4a1f-aa58-1619355f075b", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["aa3d3e5b-74a3-47f6-b9aa-d6e248e950e5"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0904-7505-04)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0904-7505-04", "marketing_start_date": "20241125"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-7505-61)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0904-7505-61", "marketing_start_date": "20241125"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "0904-7505_a51e3361-63f9-4a1f-aa58-1619355f075b", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0904-7505", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20241125", "listing_expiration_date": "20261231"}